Login about (844) 217-0978

Mark Varney

In the United States, there are 113 individuals named Mark Varney spread across 34 states, with the largest populations residing in Florida, California, Ohio. These Mark Varney range in age from 40 to 71 years old. Some potential relatives include Lori Varney, Gina Varney, Paul Schirrmacher. You can reach Mark Varney through various email addresses, including mvar***@hotmail.com, missy239***@yahoo.com, varneym***@hotmail.com. The associated phone number is 352-795-2257, along with 6 other potential numbers in the area codes corresponding to 480, 207, 276. For a comprehensive view, you can access contact details, phone numbers, addresses, emails, social media profiles, arrest records, photos, videos, public records, business records, resumes, CVs, work history, and related names to ensure you have all the information you need.

Public information about Mark Varney

Resumes

Resumes

Mark Varney

Mark Varney Photo 1
Location:
Phoenix, AZ
Industry:
Computer Software
Work:
Microsoft Alumni Network
Retired Microsoft
Principal Program Manager Lead Microsoft Jun 2007 - Jun 2010
Senior Engagement Manager Microsoft Jan 2005 - Jun 2007
Engagement Executive Microsoft Oct 1995 - Jun 2005
Managing Consultant
Education:
Arizona State University
Bachelor of Science In Engineering, Bachelors, Industrial Engineering
Skills:
Cloud Computing, Saas, Program Management, Business Intelligence, Enterprise Software, Software Project Management, Product Management, Enterprise Architecture, Partner Management, Software Development, Management, Agile Methodologies

Mark Varney

Mark Varney Photo 2
Location:
Chesapeake, OH
Industry:
Transportation/Trucking/Railroad
Work:

Trk Driver

Huntinton East High School

Mark Varney Photo 3
Location:
Houston, TX
Industry:
Electrical/Electronic Manufacturing
Work:
Advance Battery Co
Sales Consultant Continental Battery Jun 1, 2013 - Feb 2014
Sales Consultant Cbc Battery Dec 2009 - Mar 2013
General Manager Interstate Batteries Apr 1993 - Mar 2008
General Manager and Route Sales Manager Houston Texas Apr 1993 - Mar 2008
Huntinton East High School
Education:
San Jacinto College
Huntinton East High School
Skills:
Negotiation, Cold Calling, Logistics, New Business Development, Customer Service, Sales Operations, Sales Management, Inventory Management, Batteries, Account Management, Purchasing, Forecasting, Process Scheduler, B2B, Key Account Management, Contract Management, Sales, Contract Negotiation, Income Statement, Direct Sales, Pricing, Supply Chain Management, Supply Chain, Operations Management, Manufacturing, Product Development, Automotive, P&L

School Psychologist

Mark Varney Photo 4
Location:
San Andreas, CA
Work:
Calaveras County Office of Education
School Psychologist

Global Technology Analyst

Mark Varney Photo 5
Location:
Charlotte, NC
Work:
Bank of America
Global Technology Analyst
Education:
University of North Carolina at Charlotte 2017 - 2019
Bachelors

Court Deputy

Mark Varney Photo 6
Location:
Concord, NH
Industry:
Law Enforcement
Work:
Concord Hospital
Security Officer Town of Boscawen Nh Jul 2011 - Oct 2014
Training Officer and Corporal Nh Police Standards & Training Council Aug 2004 - Jul 2011
Academy Bureau Commander Us Army Jul 1975 - Aug 1995
Chief Warrant Officer Three, Cw3 Merrimack County Sheriff Jul 1975 - Aug 1995
Court Deputy
Education:
University Systems of Nh
Bachelors, Criminal Justice
Skills:
Criminal Investigations, Criminal Justice, Emergency Management, Homeland Security, Public Safety, Police, Military, Firearms, Law Enforcement, Crime Prevention, Patrol, Interrogation, Emergency Services, Counterterrorism, Private Investigations, Law Enforcement Operations, Police Training, Field Training, Investigation, Evidence, Nims, Taser, Enforcement, Weapons of Mass Destruction, Tactics, Government, Executive Protection, Workplace Violence, Policy, Community Policing, First Responder, Preparedness, Swat, Counterintelligence, Field Training Officer, Personal Protection, Risk Assessment, Hostage Negotiator, Certified Firearms Instructor, Active Shooter, Crime Scene Investigations, Crime Scene
Interests:
Friends and My Harley Davidson Tri Glide
My Family

Owner

Mark Varney Photo 7
Work:
Varney Custom Painting
Owner

Lead Carpenter

Mark Varney Photo 8
Location:
1 Main St, Whitinsville, MA 01588
Industry:
Marketing And Advertising
Work:
Access Tca
Lead Carpenter

Phones & Addresses

Name
Addresses
Phones
Mark A Varney
941-429-5880
Mark N. Varney
352-795-2257
Mark A Varney
508-839-4272
Mark A Varney
508-366-1857, 508-839-4272
Mark S. Varney
480-726-7266
Mark A Varney
508-393-0817
Mark A Varney
508-347-3277

Business Records

Name / Title
Company / Classification
Phones & Addresses
Mark Varney
Principal
Mark Varney Construction
Single-Family House Construction
545 Georgene Rd, Grenelefe, FL 33844
Mark T Varney
Vice President
D & D AUTO & FLEET, INC
Transportation Services
6211 Blanding Blvd, Jacksonville, FL 32244
3435 Sara Dr, Jacksonville, FL 32277
1163 Eagle Bnd Ct, Jacksonville, FL 32226
904-777-5115
Mark Varney
Partner
Legatomedia
Miscellaneous Publishing
17531 Dunn Rd, Hubbard, OR 97032
Mark A. Varney
President
CORTEX PHARMACEUTICALS, INC
Manufacturing Pharmaceutical Preparations · Mfg Pharmaceutical Preparations · Pharmaceutical Preparation Manufacturing · Research & Development in Biotechnology · Bolt, Nut, Screw, Rivet, and Washer Manufacturing
325 Greenway Rd, Ridgewood, NJ 07450
15241 Barranca Pkwy, Irvine, CA 92618
15231 Barranca Pkwy, Irvine, CA 92618
949-727-3157, 949-727-3657
Mark Varney
President, Vice President
VARNEY HOME SERVICES INC
5464 Prime Ter, North Port, FL 34286
5331 Burdette, North Port, FL 34287
Mark Varney
Owner
Varney Custom Painting
Painting/Paper Hanging Contractor · House Painters · Interior Painters
249 Burma Rd, Ramona, CA 92065
760-788-7122
Mark A. Varney
President
NEUROLIXIS, INC
Pharmaceutical Preparations
34145 Pacific Coast Hwy #504, Dana Point, CA 92629
29432 Clipper Way, Laguna Beach, CA 92677
3210 Merryfield Row, San Diego, CA 92121
525 B St, San Diego, CA 92101
Mark Varney
Owner
D & D Auto & Fleet Care
General Auto Repair · Auto Repair
6211 Blanding Blvd, Jacksonville, FL 32244
904-777-5115

Publications

Us Patents

Method For Treating Movement Disorders With Befiradol

US Patent:
2017023, Aug 24, 2017
Filed:
Jul 9, 2015
Appl. No.:
15/310415
Inventors:
- Boulogne-Billancourt, FR
Laurence DEL FRARI - Trebons Sur La Grasse, FR
Valérie BRUNNER - Saint Orens De Gameville, FR
Adrian NEWMAN TANCREDI - Castres, FR
Mark VARNEY - Dana Point CA, US
Assignee:
PIERRE FABRE MEDICAMENT - Boulogne-Billancourt
International Classification:
A61K 31/4545
A61K 9/00
A61K 47/38
Abstract:
The present invention relates to a method of treatment of movement disorders, comprising administering to a patient in need thereof an effective amount of befiradol, where in the administering step provides an average patient's maximum plasma concentration of befiradol below 15 ng/mL which occurs more than 4 hours post administration, said method minimizing side effects of dizziness and nausea. Sustained release pharmaceutical compositions that can be used according to this method are also described.

Compounds For Treating Disorders Sensitive To Serotoninergic Regulation Controlled By The 5-Ht1A Receptors

US Patent:
2019019, Jun 27, 2019
Filed:
Jun 23, 2017
Appl. No.:
16/312847
Inventors:
- Labruguiere, FR
- Krakow, PL
Adrian NEWMAN-TANCREDI - Castres, FR
Mark Andrew VARNEY - Dana Point CA, US
Assignee:
NEUROLIXIS - Labruguiere
UNIVERSITE JAGELLONE - Krakow
International Classification:
C07D 211/38
C07D 405/12
C07D 401/12
C07D 401/14
A61P 25/24
A61P 25/22
A61P 25/14
Abstract:
The invention concerns compounds that possess a high affinity at 5-HTreceptors and an agonist efficacy, as measured by Emax values from a cellular activation assay, that is higher than that of the compounds described in prior art. The capacity of the compounds of the invention to activate an effector protein complex is higher than that the most efficacious agonist described in prior art. Compounds of the invention also exhibit an exceptionally high selectivity (Ki ratio greater than 1000-fold) with respect, in particular, to dopamine D2 receptors and adrenergic receptors of the alpha1 subtype. This selectivity which constitutes a great advantage since it means that the compounds will avoid inducing (central and peripheral) effects associated with activating or inhibiting such receptors.

Pyridine Derivatives

US Patent:
6656957, Dec 2, 2003
Filed:
Nov 27, 2000
Appl. No.:
09/722803
Inventors:
Hans Allgeier - Lörrach, DE
Yves Auberson - Allschwil, CH
Michel Biollaz - Binningen, CH
Nicholas David Cosford - San Diego CA
Fabrizio Gasparini - Lausen, CH
Roland Heckendorn - Arlesheim, CH
Edwin Carl Johnson - San Diego CA
Rainer Kuhn - Lörrach, DE
Mark Andrew Varney - San Diego CA
Assignee:
Novartis AG - Basel
Sibia Neurosciences Inc. - La Jolla CA
International Classification:
C07D40112
US Classification:
514332, 51425218, 514256, 514277, 514312, 514338, 514342, 514352, 544333, 544360, 546153, 5462804, 5462824, 5462337, 546346
Abstract:
A compound of formula I wherein X represents an optionally halo-substituted (C )alkynylene group bonded via vicinal unsaturated carbon atoms.

Method For Treating Movement Disorders With Befiradol

US Patent:
2020013, May 7, 2020
Filed:
Dec 17, 2019
Appl. No.:
16/717019
Inventors:
- Boulogne-Billancourt, FR
Laurence DEL FRARI - Trebons Sur La Grasse, FR
Valérie BRUNNER - Saint Orens De Gameville, FR
Adrian NEWMAN TANCREDI - Castres, FR
Mark VARNEY - Dana Point CA, US
Assignee:
PIERRE FABRE MEDICAMENT - Boulogne-Billancourt
International Classification:
A61K 31/4545
A61K 31/395
A61K 31/495
A61K 9/00
A61K 47/38
Abstract:
The present invention relates to a method of treatment of movement disorders, comprising administering to a patient in need thereof an effective amount of befiradol, wherein the administering step provides an average patient's maximum plasma concentration of befiradol below 15 ng/mL which occurs more than 4 hours post administration, said method minimizing side effects of dizziness and nausea. Sustained release pharmaceutical compositions that can be used according to this method are also described.

Use Of Selective Serotonin 5-Ht1A Receptor Agonists For Treating Side-Effects Of Vmat Inhibitors

US Patent:
2020015, May 21, 2020
Filed:
Jul 20, 2018
Appl. No.:
16/630938
Inventors:
- Labruguiere, FR
- Krakow, PL
Adrian NEWMAN-TANCREDI - Castres, FR
Mark Andrew VARNEY - Dana Point CA, US
International Classification:
A61K 31/4545
A61K 31/4433
A61K 31/4418
A61K 31/506
A61K 31/135
A61P 25/08
A61K 31/496
A61K 9/00
A61K 31/428
Abstract:
The present invention relates to the reduction of the side-effects induced by tetrabenazine or other inhibitors of vesicular monoamine transporter (VMAT), in the treatment of central nervous system disorders such as Huntington's disease, L-DOPA-induced dyskinesias in Parkinson's disease, Tourette's syndrome or tardive dyskinesia. The invention comprises administering to a patient in need thereof an effective amount of activates selective serotonin 5-IITreceptors agonist, whereby the side-effects of depression or Parkinsonism induced by tetrabenazine or other VMAT inhibitors are minimized

Methods Of Modulating Processes Mediated By Excitatory Amino Acid Receptors

US Patent:
6956049, Oct 18, 2005
Filed:
Aug 31, 1999
Appl. No.:
09/387135
Inventors:
Nicholas D. P. Cosford - San Diego CA, US
Ian A. McDonald - San Diego CA, US
Stephen D. Hess - San Diego CA, US
Mark A. Varney - San Diego CA, US
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K031/425
A51K031/425
C07D277/00
US Classification:
514365, 514369, 514370, 514371, 514372, 548146
Abstract:
In accordance with the present invention, there are provided methods of modulating the activity of excitatory amino acid receptors using a specifically defined class of heterocyclic compounds. In one embodiment, there are provided methods of modulating metabotropic glutamate receptors. The present invention also discloses methods of treating disease using heterocyclic compounds. Diseases contemplated include cerebral ischemia, chronic neurodegeneration, psychiatric disorders, schizophrenia, mood disorders, emotion disorders, disorders of extrapyramidal motor function, obesity, disorders of respiration, motor control and function, attention deficit disorders, concentration disorders, pain disorders, neurodegenerative disorders, epilepsy, convulsive disorders, eating disorders, sleep disorders, sexual disorders, circadian disorders, drug withdrawal, drug addiction, compulsive disorders, anxiety, panic disorders, depressive disorders, skin disorders, retinal ischemia, retinal degeneration, glaucoma, disorders associated with organ transplantation, asthma, ischemia and astrocytomas. The invention further discloses methods of preventing disease conditions related to diseases of the pulmonary system, diseases of the nervous system, diseases of the cardiovascular system, diseases of the gastrointestinal system, diseases of the endocrine system, diseases of the exocrine system, diseases of the skin, cancer and diseases of the ophthalmic system. The invention also discloses pharmaceutically acceptable salt forms of heterocyclic compounds.

Method For Treating Movement Disorders With Befiradol

US Patent:
2021033, Nov 4, 2021
Filed:
Jun 25, 2021
Appl. No.:
17/359182
Inventors:
- Boulogne-Billancourt, FR
Laurence DEL FRARI - Trebons Sur La Grasse, FR
Valérie BRUNNER - Saint Orens De Gameville, FR
Adrian NEWMAN TANCREDI - Castres, FR
Mark VARNEY - Dana Point CA, US
Assignee:
PIERRE FABRE MEDICAMENT - Boulogne-Billancourt
International Classification:
A61K 31/444
A61K 31/395
A61K 31/495
A61K 9/00
A61K 31/4545
A61K 47/38
Abstract:
The present invention relates to a method of treatment of movement disorders, comprising administering to a patient in need thereof an effective amount of befiradol, wherein the administering step provides an average patient's maximum plasma concentration of befiradol below 15 ng/mL which occurs more than 4 hours post administration, said method minimizing side effects of dizziness and nausea. Sustained release pharmaceutical compositions that can be used according to this method are also described.

Combinations Of Eszopiclone And Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-N-Methyl-1-Napthalenamine Or Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine, And Methods Of Treatment Of Menopause And Mood, Anxiety, And Cognitive Disorders

US Patent:
2013006, Mar 14, 2013
Filed:
Nov 9, 2012
Appl. No.:
13/673076
Inventors:
Thomas WESSEL - Lenox MA, US
Karim LALJI - West Vancouver, CA
Mark VARNEY - Laguna Niguel CA, US
Roger P. BAKALE - Malvern PA, US
Surendra P. SINGH - Shrewsbury MA, US
H. Scott WILKINSON - Westborough MA, US
Xiping SU - Woodbridge CT, US
Zhengxu HAN - Shrewsbury MA, US
Stefan G. KOENIG - Shrewsbury MA, US
Assignee:
SUNOVION PHARMACEUTICALS INC. - Marlborough MA
International Classification:
A61K 31/4985
A61P 25/00
A61P 25/16
A61P 25/24
A61P 25/28
A61P 15/12
A61P 25/22
US Classification:
514249
Abstract:
One aspect of the present invention relates to pharmaceutical compositions containing two or more active agents that when taken together can be used to treat, e.g., menopause, mood disorders, anxiety disorders, or cognitive disorders. The first component of the pharmaceutical composition is a sedative eszopiclone. The second component of the pharmaceutical composition is trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydr... or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydr... The present invention also relates to a method of treating menopause, perimenopause, mood disorders, anxiety disorders, and cognitive disorders.

FAQ: Learn more about Mark Varney

Where does Mark Varney live?

Kalamazoo, MI is the place where Mark Varney currently lives.

How old is Mark Varney?

Mark Varney is 56 years old.

What is Mark Varney date of birth?

Mark Varney was born on 1968.

What is Mark Varney's email?

Mark Varney has such email addresses: mvar***@hotmail.com, missy239***@yahoo.com, varneym***@hotmail.com, markvar***@sbcglobal.net, mark.var***@blackplanet.com, james.mur***@aol.com. Note that the accuracy of these emails may vary and they are subject to privacy laws and restrictions.

What is Mark Varney's telephone number?

Mark Varney's known telephone numbers are: 352-795-2257, 480-726-7266, 207-723-4392, 276-783-7992, 415-681-5877, 508-587-8763. However, these numbers are subject to change and privacy restrictions.

Who is Mark Varney related to?

Known relatives of Mark Varney are: Karen Varney, Laura Varney, Andres Hernandez, Daniel Kukla, Don Kukla, Louise Kukla, Ann Kukla. This information is based on available public records.

What are Mark Varney's alternative names?

Known alternative names for Mark Varney are: Karen Varney, Laura Varney, Andres Hernandez, Daniel Kukla, Don Kukla, Louise Kukla, Ann Kukla. These can be aliases, maiden names, or nicknames.

What is Mark Varney's current residential address?

Mark Varney's current known residential address is: 7551 Hampton Oaks Dr, Portage, MI 49024. Please note this is subject to privacy laws and may not be current.

What are the previous addresses of Mark Varney?

Previous addresses associated with Mark Varney include: 5906 E Farmstead Dr, Tucson, AZ 85756; 12310 Darkwood, San Diego, CA 92129; 13202 Thunderhead, San Diego, CA 92129; 5331 Burdette Ter, North Port, FL 34287; 8590 Price Blvd, North Port, FL 34291. Remember that this information might not be complete or up-to-date.

What is Mark Varney's professional or employment history?

Mark Varney has held the following positions: Principal Program Manager Lead / Microsoft; Security Officer / Concord Hospital; Vice President Sales / Kinsley Power Systems; Intern / Fastenal; Chief Scientific Office / Psychogenics; Director of Sales and Marketing / Minuteman Press of Newtown. This is based on available information and may not be complete.

People Directory:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z